Patent Extension Application for SERZONE® Patent No. 4,338,317 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-1995-E-0065

Patent Extension Application for SERZONE® Patent No. 4,338,317

Documents

Comments

Description

CLOSED DATE: 03/16/1995 Docket Status: CLOSED

Comment Period OpensApr 24, 1995

Comment Period ClosesJun 24, 1995

Type	Title	Posted	Comments	Status
Other	Letter from FDA Office of Health Affairs to The Honorable Bruce Lehman	Oct 13, 2017	--

PATENT EXTENSION APPLICATION

PATENT NO. 4,338,317

SERZONE

CLOSED

BRISTOL-MYERS SQUIBB CO